Letter: optimising response to ustekinumab therapy for patients with Crohn's disease-author's reply
1Department of Gastroenterology, Sheba Medical center, Tel Hashomer, Israel.
Alimentary Pharmacology & Therapeutics
|August 28, 2020
Abstract
No abstract available in PubMed .


